1 / 10

Primary Cells Market Size Strong Revenue and Competitive Outlook

The increasing investments in biomedical research coupled with growth in the occurrence of diseases such as cancer drive the growth of the primary cell culture market. Increasing demand for advanced drug development and testing, growing applications in genetic engineering and virology, and stringent regulations regarding animal testing boost the growth of this market.

priyanka1988
Download Presentation

Primary Cells Market Size Strong Revenue and Competitive Outlook

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Primary Cells Market Market Size Worth $1.79 Billion By 2028 | CAGR: 8.4%

  2. Primary Cells Market Size Worth $1.79 Billion By 2028 “According to Polaris Market Research report, Primary Cells market is witnessing a major transformation and is projected to reach $1.79 Billion By 2028 registering a CAGR of 8.4% during the forecast period 2021 to 2028.” The global Primary Cells market growth is driven by some of the key factors such as growing awareness among consumers, increasing investments by private-public organizations, and favorable government policies. Additionally, many prominent players present in the market are concentrating on the adoption of new technology and product launches to obtain a competitive edge, which in turn contributes to the Primary Cells market growth. The regulatory agencies are also playing a key role as the major driving force for the market, by safeguarding the quality of product/service offerings as well as accelerating new approvals. Primary Cells Market Report Scope: The study provides a comprehensive view of the Primary Cells market by segmenting it based on Source, Type, End-Use and region. All the segments of the market have been thoroughly analyzed based on present and future trends. The research report has identified the key segments contributing most to the Primary Cells market growth in terms of revenue along with other vital factors impacting the market dynamics. Further, the market analysis covered in the report also answers the imperative question for new entrants and existing players operating in the market. Browse Detailed Research Report On Primary Cells Market Analysis: https://www.polarismarketresearch.com/industry-analysis/primary-cells-market - 2 -

  3. Primary Cells Market Size Worth $1.79 Billion By 2028 By Source By Type By End-Use By Region •Animal •Human •Hematopoietic •Hepatocytes •Renal •Gastrointestinal •Skin •Lung •Others •Medical •Pharmaceutical & Biotechnology Companies •Research Institutes •Others •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Impact Analysis of COVID-19 on Primary Cells Market The global Primary Cells market is anticipated to continue its growth amid the covid-19 pandemic. After giving insightful information on market behavior pre and post COVID-19 pandemic, the report also sheds light on the key strategic moves to overcome the adverse impact of COVID-19 on business and turn the positive impact into a lucrative opportunity. Regional Outlook The regional market of North America is witnessing a significant rise in the growth rate and is expected to account for the largest market share over the forecast period. The market is flourishing as a result of its increasing application scope and ample availability of vital resources. During the forecast period, the Asia Pacific region is estimated to garner the highest CAGR for the Primary Cells market, owing to the presence of several leading local and international players operating in the regional market. Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Primary Cells market in different regions and how market players devising effective strategies to mitigate the effect of the pandemic: https://www.polarismarketresearch.com/industry- analysis/primary-cells-market/speak-to-analyst - 3 -

  4. Primary Cells Market Size Worth $1.79 Billion By 2028 Competitive Landscape Leading companies holding significant market shares in the Primary Cells market are analyzed considering their market shares, growth rates, market revenue, business strategies, and latest developments. Recent events for these major companies such as acquisitions, research initiatives, technological advancements, new solution/product launches, and geographical expansions considered in finalizing their position in the market. According to Polaris Market Research, the leading players with a noteworthy share in the Primary Cells market include Cell Biologics, Inc., ZenBio, Inc., Stem Cell Technologies, Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Cell Applications, Inc., Pelobiotech, Merck KGaA, Axol Bioscience Ltd, Promocell, ALLCells, Lonza Group, AG, and Creative Bioarray. Request for sample: https://www.polarismarketresearch.com/industry-analysis/primary-cells- market/request-for-sample Table of Contents 1.Chapter 1. Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Chapter 2. Executive Summary 2.1.Market Highlights 3.Chapter 3. Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Chapter 4. Primary Cells Market Insights 4.1.Primary Cells – Industry snapshot 4.2.Primary Cells Market Dynamics 4.2.1.Drivers and Opportunities 4.2.2.Restraints and Challenges 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers 4.3.2.Threats of New Entrants 4.3.3.Bargaining Power of Buyers 4.3.4.Threats of Substitute 4.3.5.Rivalry among existing firms 4.4.Primary Cells Market PESTLE Analysis 4.5.Value Chain Analysis 4.6.Competitive Ranking Analysis, 2020 - 4 -

  5. Primary Cells Market Size Worth $1.79 Billion By 2028 5.Chapter 5. Primary Cells Market Assessment by Source 5.1.Introduction 5.1.1.Global Primary Cells Market Share, By Source, 2020 & 2028 5.2.Animal Primary Cells 5.2.1.Global Primary Cells Market, by Animal Primary Cells, 2016-2028 (USD Million) 5.2.2.Global Primary Cells Market, by Animal Primary Cells, by Region, 2016-2028 (USD Million) 5.3.Human Primary Cells 5.3.1.Global Primary Cells Market, by Human Primary Cells, 2016-2028 (USD Million) 5.3.2.Global Primary Cells Market, by Human Primary Cells, by Region, 2016-2028 (USD Million) 6.Chapter 6. Primary Cells Market Assessment by Type 6.1.Introduction 6.1.1.Global Primary Cells Market Share, By Type, 2020 & 2028 6.2.Hematopoietic 6.2.1.Global Primary Cells Market, by Hematopoietic, 2016-2028 (USD Million) 6.2.2.Global Primary Cells Market, by Hematopoietic, by Region, 2016-2028 (USD Million) 6.3.Hepatocytes 6.3.1.Global Primary Cells Market, by Hepatocytes, 2016-2028 (USD Million) 6.3.2.Global Primary Cells Market, by Hepatocytes, by Region, 2016-2028 (USD Million) 6.4.Renal Cells 6.4.1.Global Primary Cells Market, by Renal Cells, 2016-2028 (USD Million) 6.4.2.Global Primary Cells Market, by Renal Cells, by Region, 2016-2028 (USD Million) 6.5.Gastrointestinal Cells 6.5.1.Global Primary Cells Market, by Gastrointestinal Cells, 2016-2028 (USD Million) 6.5.2.Global Primary Cells Market, by Gastrointestinal Cells, by Region, 2016-2028 (USD Million) 6.6.Skin Cells 6.6.1.Global Primary Cells Market, by Skin Cells, 2016-2028 (USD Million) 6.6.2.Global Primary Cells Market, by Skin Cells, by Region, 2016-2028 (USD Million) 6.7.Lung Cells 6.7.1.Global Primary Cells Market, by Lung Cells, 2016-2028 (USD Million) 6.7.2.Global Primary Cells Market, by Lung Cells, by Region, 2016-2028 (USD Million) 6.8.Others 6.8.1.Global Primary Cells Market, by Others, 2016-2028 (USD Million) 6.8.2.Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million) 7.Chapter 7. Primary Cells Market Assessment by End-User 7.1.Introduction 7.1.1.Global Primary Cells Market Share, By End-User, 2020 & 2028 7.2.Medical 7.2.1.Global Primary Cells Market, by Medical, 2016-2028 (USD Million) 7.2.2.Global Primary Cells Market, by Medical, by Region, 2016-2028 (USD Million) 7.3.Pharmaceutical and Biotechnology Companies 7.3.1.Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, 2016-2028 (USD Million) 7.3.2.Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, by Region, 2016-2028 (USD Million) 7.4.Research Institutes 7.4.1.Global Primary Cells Market, by Research Institutes, 2016-2028 (USD Million) - 5 -

  6. Primary Cells Market Size Worth $1.79 Billion By 2028 7.4.2.Global Primary Cells Market, by Research Institutes, by Region, 2016-2028 (USD Million) 7.5.Others 7.5.1.Global Primary Cells Market, by Others, 2016-2028 (USD Million) 7.5.2.Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million) 8.Chapter 8. Primary Cells Market Assessment by Geography 8.1.Introduction 8.1.1.Global Primary Cells Market Share, By Geography, 2020 & 2028. 8.2.Primary Cells Market – North America 8.2.1.North America: Primary Cells Market, by Country, 2016-2028 (USD Million) 8.2.2.North America: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.2.3.North America: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.2.4.North America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.2.5.Primary Cells Market – U.S. 8.2.5.1. U.S.: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.2.5.2. U.S.: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.2.5.3. U.S.: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.2.6.Primary Cells Market – Canada 8.2.6.1. Canada: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.2.6.2. Canada: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.2.6.3. Canada: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.3.Primary Cells Market – Europe 8.3.1.Europe: Primary Cells Market, by Country, 2016-2028 (USD Million) 8.3.2.Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.3.3.Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.3.4.Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.3.5.Primary Cells Market – Germany 8.3.5.1. Germany: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.3.5.2. Germany: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.3.5.3. Germany: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.3.6.Primary Cells Market – UK 8.3.6.1. UK: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.3.6.2. UK: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.3.6.3. UK: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.3.7.Primary Cells Market – France 8.3.7.1. France: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.3.7.2. France: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.3.7.3. France: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.3.8.Primary Cells Market – Italy 8.3.8.1. Italy: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.3.8.2. Italy: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.3.8.3. Italy: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.3.9.Primary Cells Market – Spain 8.3.9.1. Spain: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.3.9.2. Spain: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.3.9.3. Spain: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.3.10.Primary Cells Market – Rest of Europe 8.3.10.1.Rest of Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.3.10.2.Rest of Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million) - 6 -

  7. Primary Cells Market Size Worth $1.79 Billion By 2028 8.3.10.3.Rest of Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.4.Primary Cells Market – Asia-Pacific 8.4.1.Asia Pacific: Primary Cells Market, by Country, 2016-2028 (USD Million) 8.4.2.Asia-Pacific: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.4.3.Asia-Pacific: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.4.4.Asia-Pacific: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.4.5.Primary Cells Market – China 8.4.5.1. China: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.4.5.2. China: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.4.5.3. China: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.4.6.Primary Cells Market – India 8.4.6.1. India: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.4.6.2. India: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.4.6.3. India: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.4.7.Primary Cells Market – Japan 8.4.7.1. Japan: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.4.7.2. Japan: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.4.7.3. Japan: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.4.8.Primary Cells Market – South Korea 8.4.8.1. South Korea: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.4.8.2. South Korea: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.4.8.3. South Korea: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.4.9.Primary Cells Market – Rest of APAC 8.4.9.1. Rest of APAC: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.4.9.2. Rest of APAC: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.4.9.3. Rest of APAC: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.5.Primary Cells Market – Latin America 8.5.1.Latin America: Primary Cells Market, by Country, 2016-2028 (USD Million) 8.5.2.Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.5.3.Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.5.4.Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.5.5.Primary Cells Market – Brazil 8.5.5.1. Brazil: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.5.5.2. Brazil: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.5.5.3. Brazil: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.5.6.Primary Cells Market – Mexico 8.5.6.1. Mexico: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.5.6.2. Mexico: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.5.6.3. Mexico: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.5.7.Primary Cells Market – Colombia 8.5.7.1. Colombia: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.5.7.2. Colombia: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.5.7.3. Colombia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.5.8.Primary Cells Market – Rest of Latin America 8.5.8.1. Rest of Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.5.8.2. Rest of Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million) - 7 -

  8. Primary Cells Market Size Worth $1.79 Billion By 2028 8.5.8.3. Rest of Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.6.Primary Cells Market – Middle East and Africa 8.6.1.Middle East & Africa: Primary Cells Market, by Country, 2016-2028 (USD Million) 8.6.2.Middle East & Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.6.3.Middle East & Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.6.4.Middle East & Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.6.5.Primary Cells Market – Saudi Arabia 8.6.5.1. Saudi Arabia: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.6.5.2. Saudi Arabia: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.6.5.3. Saudi Arabia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.6.6.Primary Cells Market – South Africa 8.6.6.1. South Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.6.6.2. South Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.6.6.3. South Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.6.7.Primary Cells Market – Israel 8.6.7.1. Israel: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.6.7.2. Israel: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.6.7.3. Israel: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.6.8.Primary Cells Market – UAE 8.6.8.1. UAE: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.6.8.2. UAE: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.6.8.3. UAE: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 8.6.9.Primary Cells Market – Rest of MEA 8.6.9.1. Rest of MEA: Primary Cells Market, By Source, 2016 - 2028 (USD Million) 8.6.9.2. Rest of MEA: Primary Cells Market, By Type, 2016 - 2028 (USD Million) 8.6.9.3. Rest of MEA: Primary Cells Market, By End-User, 2016 - 2028 (USD Million) 9.Chapter 9. Competitive Landscape 9.1.Expansion and Product Launch Analysis 9.1.1.Expansion 9.1.2.Product Launch 9.2.Partnerships/Collaborations/Agreements/Exhibitions 10.Chapter 10. Company Profiles 10.1. Cell Biologics, Inc. 10.1.1.Business Overview 10.1.2.Financial Snapshot 10.1.3.Products and Services Benchmarking 10.1.4.Recent Development 10.2. ZenBio, Inc. 10.2.1.Business Overview 10.2.2.Financial Snapshot 10.2.3.Products and Services Benchmarking 10.2.4.Recent Development 10.3. Stem Cell Technologies 10.3.1.Business Overview 10.3.2.Financial Snapshot 10.3.3.Products and Services Benchmarking 10.3.4.Recent Development - 8 -

  9. Primary Cells Market Size Worth $1.79 Billion By 2028 10.4. Sigma-Aldrich 10.4.1.Business Overview 10.4.2.Financial Snapshot 10.4.3.Products and Services Benchmarking 10.4.4.Recent Development 10.5. Thermo Fisher Scientific 10.5.1.Business Overview 10.5.2.Financial Snapshot 10.5.3.Products and Services Benchmarking 10.5.4.Recent Development 10.6. Cureline 10.6.1.Business Overview 10.6.2.Financial Snapshot 10.6.3.Products and Services Benchmarking 10.6.4.Recent Development 10.7. American Type Culture Collection 10.7.1.Business Overview 10.7.2.Financial Snapshot 10.7.3.Products and Services Benchmarking 10.7.4.Recent Development 10.8. Cell Applications, Inc. 10.8.1.Business Overview 10.8.2.Financial Snapshot 10.8.3.Products and Services Benchmarking 10.8.4.Recent Development 10.9. Pelobiotech 10.9.1.Business Overview 10.9.2.Financial Snapshot 10.9.3.Products and Services Benchmarking 10.9.4.Recent Development 10.10. Merck KGaA 10.10.1. Business Overview 10.10.2. Financial Snapshot 10.10.3. Products and Services Benchmarking 10.10.4. Recent Development 10.11. Axol Bioscience Ltd 10.11.1. Business Overview 10.11.2. Financial Snapshot 10.11.3. Products and Services Benchmarking 10.11.4. Recent Development 10.12. Promocell 10.12.1. Business Overview 10.12.2. Financial Snapshot 10.12.3. Products and Services Benchmarking 10.12.4. Recent Development 10.13. ALLCells 10.13.1. Business Overview 10.13.2. Financial Snapshot 10.13.3. Products and Services Benchmarking 10.13.4. Recent Development - 9 -

  10. Primary Cells Market Size Worth $1.79 Billion By 2028 10.14. Lonza Group, AG 10.14.1. 10.14.2. 10.14.3. 10.14.4. 10.15. Creative Bioarray 10.15.1. 10.15.2. 10.15.3. 10.15.4. Business Overview Financial Snapshot Products and Services Benchmarking Recent Development Business Overview Financial Snapshot Products and Services Benchmarking Recent Development Access Press Release on Primary Cells Market: https://www.polarismarketresearch.com/press- releases/primary-cells-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 10 -

More Related